Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

L.A. McKeown

October 08, 2021

News Conference News ESC 2020

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Yael L. Maxwell

September 01, 2020

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Daily News

Mortality From Heart Failure Increasing in United States

Michael O'Riordan

May 06, 2019

News Daily News

Many CVD Risk Factors Remain Uncontrolled in Men and Women, but Emphasis Differs

Lucy Hicks

February 21, 2019

News Daily News

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

Michael O'Riordan

November 26, 2018

News Daily News

Certain Risk Factors Carry Higher MI Risk in Women Than in Men

Shelley Wood

November 23, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

News Daily News

Midlife Vascular Risk Factors Linked to Amyloid Plaques in Alzheimer’s

Alison Palkhivala

April 11, 2017

News Daily News

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Yael L. Maxwell

September 14, 2016

News Daily News

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

Yael L. Maxwell

September 14, 2016

News Daily News

Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook

L.A. McKeown

August 04, 2016

News Daily News

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

Michael O'Riordan

July 13, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

Advertisement

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Good News and Bad for High-Intensity Statin Use in ASCVD

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Mortality From Heart Failure Increasing in United States

Many CVD Risk Factors Remain Uncontrolled in Men and Women, but Emphasis Differs

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

Certain Risk Factors Carry Higher MI Risk in Women Than in Men

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Midlife Vascular Risk Factors Linked to Amyloid Plaques in Alzheimer’s

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content